The impact of coronary revascularization methods (coronary artery bypass graft [CABG] surgery and stent implantation) on clinical outcome has not been determined yet in patients with systolic heart failure (SHF). We examined outcomes in patients discharged from our hospital after hospitalization for decompensated SHF. Of 637 patients with SHF (mean age, 64 ± 13 years; mean ejection fraction, 26.5% ± 9%), 402 patients (63%) had coronary artery disease (CAD) and 235 patients (37%) had no CAD; 223 patients (35%) died because of cardiovascular reasons during follow-up. Patients who had stenting alone and patients who had CABG surgery and stenting had better prognosis than patients with CAD but no revascularization procedure (P < .001 and P = .013, respectively). In the patients with SHF having CAD who had stenting and CABG surgery + stenting may have better prognosis compared with patients with CAD who had no revascularization procedure in their past.
ChatterjeeK. Is detection of hibernating myocardium necessary in deciding revascularization in systolic heart failure?Am J Cardiol. 2010;106(2):236–242.
2.
AhmedMIMujibMDesaiRV. Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched study. Int J Cardiol. 2010:144(3):383–388.
3.
GottdienerJSArnoldAMAurigemmaGP. Predictors of congestive heart failure in the elderly: the cardiovascular Health Study. J Am Coll Cardiol. 2000;35(6):1628–1637.
4.
GheorghiadeMSopkoGDe LucaL. Navigating the crossroads of coronary artery disease and heart failure. Circulation. 2006;114(11):1202–1213.
5.
HuntSAAbrahamWTChinMH. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with theAmerican College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:(12):e154–e235.
6.
FlahertyJDBaxJJDe LucaL. Acute heart failure syndromes in patients with coronary artery disease. J Am Coll Cardiol. 2009;53(3):254–263.
7.
BartBAShawLKMcCantsJr CB. Clinical determinants of mortality inpatients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol. 1997;30(4):1002–1008.
8.
FelkerGMThompsonREHareJM. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342(15):1077–1084.
9.
WestabyS. Coronary revascularization in ischemic cardiomyopathy. Surg Clin North Am. 2004;84(1):179–199.
10.
CarlsonEBCowleyMJWolfgangTCVetrovecGW. Acute changes in global and regional rest ventricular function after successful coronary angioplasty: comparative results in stable and unstable angina. J Am Coll Cardiol. 1989;13(6):1262–1269.
11.
ChatterjeeKDe MarcoTMcGlothlinD. Remodeling in systolic heart failure—effects of neurohormonal modulators—basis for current pharmacotherapy. Cardiol Today. 2005;9:270–277.
12.
BrowerRWFiorettiPSimoonsMHaalebosMRulfENHugenholtzPG. Surgical versus non-surgical management of patients soon after acute myocardial infarction. Br Heart J. 1985;54(5):460–465.
13.
NishiyamaSIwaseTIshiwataS. Comparison of long-term efficacy of medical treatment versus coronary artery bypass grafting (CABG) in multivessel coronary artery disease. Jpn Heart J. 1995;36(6):709–717.
ShenJDuYSongW. Efficacy of coronary angioplasty on long-term outcome in elderly Chinese patients with ST elevated myocardial infarction. Cell Biochem Biophys. 2010;57(2-3):59–65.
16.
SahnDJDeMariaAKissloJWeymanA. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58(6):1072–1083.
17.
CharaeonthaitaweePGershBJAraozPAGibbonsRJ. Revascularization in severe left ventricular dysfunction: the role of viability testing. J Am Coll Cardiol. 2005;46(4):567–574.
18.
JonesRH. Is it time for a randomized trial of surgical treatment of ischemic heart failure?J Am Coll Cardiol. 2001;37(5):1210–1213.
19.
PassamaniEDavisKBGillespieMJKillipT. A randomized trial of coronary artery bypass surgery. Survival in patients with a low ejection fraction. N Engl J Med. 1985;312(26):1665–1671.
20.
O’ConnorCMVelazquezEJGardnerLH. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). Am J Cardiol. 2002;90(2):101–107.
21.
CamiciPGPrasadSKRimoldiOE. Stunning, hibernation, and assessment of myocardial viability. Circulation. 2008;117(1):103–114.
22.
AmmiratiERimoldiOECamiciPG. Is there evidence supporting coronary revascularization in patients with left ventricular systolic dysfunction?Circ J. 2010;75(1):3–10.
23.
WijnsWVatnerSFCamiciPG. Hibernating myocardium. N Engl J Med. 1998;339(3):173–181.
24.
UrenNGMelinJADe BruyneBWijnsWBaudhuinTCamiciPG. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med. 1994;330(25):1782–1788.
25.
FryeRLAugustPBrooksMM. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360(24):2503–2515.
26.
ChaitmanBRHardisonRMAdlerD. The bypass angioplasty revascularization investigation 2 diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation. 2009;120(25):2529–2540.
27.
ErnePSchoenenbergerAWBurckhardtD. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: The SWISSI II randomized controlled trial. JAMA. 2007;297(18):1985–1991.
28.
AldermanELBourassaMGCohenLS. Ten-year follow-up of survival and myocardial infarction in the randomized coronary artery surgery study. Circulation. 1990;82(5):1629–1646.
29.
VelazquezEJLeeKLDejaMA; STICH Investigators. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364(17):1607–1616.
30.
GheorghiadeMFlahertyJDFonarowGC. Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure. Int J Cardiol. 2011;151(1):69–75.
31.
PocarMMonetaAGrossiADonatelliF. Coronary artery bypass for heart failure in ischemic cardiomyopathy: 17-year follow-up. Ann Thorac Surg. 2007;83(2):468–474.
32.
SerruysPWMoriceMCKappeteinAP; SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–972.
33.
Biondi ZoccaiGMorettiCAbbateA. Percutaneous coronary stenting in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis. EuroIntervention. 2007;3(3):409–415.
